isosorbide has been researched along with Acute Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimaki, Y; Ishimoto, S; Okada, K; Yamasoba, T | 1 |
| Horii, A; Kubo, T; Mitani, K; Mizuki, M; Murata, J; Tamura, M | 1 |
| Haughom, F; Kramer, B; Massie, BM | 1 |
| Bussmann, WD; Kaltenbach, M; Reifart, N; Schirmer, M | 1 |
4 other study(ies) available for isosorbide and Acute Disease
| Article | Year |
|---|---|
Trial of Chinese medicine Wu-Ling-San for acute low-tone hearing loss.
Topics: Acute Disease; Adult; Age Distribution; Aged; Diuretics, Osmotic; Drug Synergism; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glucocorticoids; Hearing Loss, Sensorineural; Humans; Isosorbide; Male; Medicine, Chinese Traditional; Middle Aged; Outpatients; Prednisolone; Retrospective Studies; Sex Distribution; Treatment Outcome | 2012 |
Endolymphatic hydrops as a cause of audio-vestibular manifestations in relapsing polychondritis.
Topics: Acute Disease; Audiometry, Evoked Response; Autoimmune Diseases; C-Reactive Protein; Diagnosis, Differential; Diuretics, Osmotic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ear Diseases; Ear, External; Endolymphatic Hydrops; Female; Hearing Loss, Sensorineural; Humans; Immunoglobulin M; Immunosuppressive Agents; Isosorbide; Meniere Disease; Middle Aged; Polychondritis, Relapsing; Prednisone; Primary Myelofibrosis; Thalidomide; Treatment Outcome | 2006 |
Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance.
Topics: Acute Disease; Adult; Aged; Blood Pressure; Exercise Test; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Isosorbide; Long-Term Care; Middle Aged; Oxygen Consumption; Rest; Time Factors; Vasodilator Agents | 1981 |
[Hemodynamic effect, effect duration and pharmacokinetics of 80 mg of isosorbide-5-mononitrate in acute myocardial infarct].
Topics: Acute Disease; Adult; Aged; Hemodynamics; Humans; Isosorbide; Isosorbide Dinitrate; Middle Aged; Myocardial Infarction | 1981 |